Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes

Fig. 2

BNP and NT-proBNP levels during treatment with placebo and linagliptin. Data are presented as baseline (pre) and end-of-treatment (post) values (a, d), and change from baseline (b, e) during placebo or linagliptin. c, f Show changes from baseline in BNP and NT-proBNP, respectively, in patients with (n = 18) CKD and in those without (n = 28; Ctrl). *p<0.05. The box plot shows median and IQR, whereas whiskers indicate Tukey range

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840